166 related articles for article (PubMed ID: 34627859)
1. Incidence and Mortality in Upper Gastrointestinal Cancer After Negative Endoscopy for Gastroesophageal Reflux Disease.
Holmberg D; Santoni G; von Euler-Chelpin MC; Färkkilä M; Kauppila JH; Maret-Ouda J; Ness-Jensen E; Lagergren J
Gastroenterology; 2022 Feb; 162(2):431-438.e4. PubMed ID: 34627859
[TBL] [Abstract][Full Text] [Related]
2. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
[TBL] [Abstract][Full Text] [Related]
3. Risk of upper gastrointestinal cancers in patients with gastroesophageal reflux disease after a negative screening endoscopy.
Shakhatreh MH; Duan Z; Avila N; Naik AD; Kramer JR; Hinojosa-Lindsey M; Chen J; El-Serag HB
Clin Gastroenterol Hepatol; 2015 Feb; 13(2):280-6. PubMed ID: 25004461
[TBL] [Abstract][Full Text] [Related]
4. Endoscopy for gastroesophageal reflux disease and survival in esophageal adenocarcinoma.
Holmberg D; Ness-Jensen E; Mattsson F; Lagergren J
Int J Cancer; 2020 Jul; 147(1):93-99. PubMed ID: 31583704
[TBL] [Abstract][Full Text] [Related]
5. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries.
Maret-Ouda J; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
JAMA Oncol; 2018 Nov; 4(11):1576-1582. PubMed ID: 30422249
[TBL] [Abstract][Full Text] [Related]
6. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.
Mäntynen T; Färkkilä M; Kunnamo I; Mecklin JP; Juhola M; Voutilainen M
Am J Gastroenterol; 2002 Oct; 97(10):2524-9. PubMed ID: 12385433
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database.
Dickman R; Mattek N; Holub J; Peters D; Fass R
Am J Gastroenterol; 2007 Jun; 102(6):1173-9. PubMed ID: 17378910
[TBL] [Abstract][Full Text] [Related]
8. A case-control study of endoscopy and mortality from adenocarcinoma of the esophagus or gastric cardia in persons with GERD.
Kearney DJ; Crump C; Maynard C; Boyko EJ
Gastrointest Endosc; 2003 Jun; 57(7):823-9. PubMed ID: 12776027
[TBL] [Abstract][Full Text] [Related]
9. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
10. Treatment of newly-diagnosed gastroesophageal reflux disease: a nationwide register-based cohort study.
Ljungdalh JS; Rubin KH; Durup J; Houlind KC
Scand J Gastroenterol; 2019 Jul; 54(7):830-837. PubMed ID: 31280616
[No Abstract] [Full Text] [Related]
11. The risk of missed gastroesophageal cancer diagnoses in users and nonusers of antisecretory medication.
Lassen A; Hallas J; de Muckadell OB
Gastroenterology; 2005 Oct; 129(4):1179-86. PubMed ID: 16230072
[TBL] [Abstract][Full Text] [Related]
12. Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic Countries.
Maret-Ouda J; Santoni G; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
Ann Surg; 2021 Dec; 274(6):e535-e540. PubMed ID: 31800492
[TBL] [Abstract][Full Text] [Related]
13. Erosive reflux disease increases risk for esophageal adenocarcinoma, compared with nonerosive reflux.
Erichsen R; Robertson D; Farkas DK; Pedersen L; Pohl H; Baron JA; Sørensen HT
Clin Gastroenterol Hepatol; 2012 May; 10(5):475-80.e1. PubMed ID: 22245963
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.
Spence AD; Busby J; Johnston BT; Baron JA; Hughes CM; Coleman HG; Cardwell CR
Gastroenterology; 2018 Mar; 154(4):849-860.e1. PubMed ID: 29122547
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of incidence and mortality for upper digestive tract cancers and results of early detection and treatment program in Feicheng, Shandong Province].
Yi L; Zhao T; Li YY; Chen WQ; Zhao DL
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 May; 51(5):403-408. PubMed ID: 28464590
[No Abstract] [Full Text] [Related]
16. Relationship of gastroesophageal reflux disease with adenocarcinoma of the distal esophagus and cardia.
Velanovich V; Hollingsworth J; Suresh P; Ben-Menachem T
Dig Surg; 2002; 19(5):349-53. PubMed ID: 12435904
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in oesophageal diseases.
Al Dulaimi D
Gastroenterol Hepatol Bed Bench; 2014; 7(3):186-9. PubMed ID: 25120902
[TBL] [Abstract][Full Text] [Related]
18. Limited diagnostic value of laryngopharyngeal lesions in patients with gastroesophageal reflux during routine upper gastrointestinal endoscopy.
Vavricka SR; Storck CA; Wildi SM; Tutuian R; Wiegand N; Rousson V; Fruehauf H; Mullhaupt B; Fried M
Am J Gastroenterol; 2007 Apr; 102(4):716-22. PubMed ID: 17397404
[TBL] [Abstract][Full Text] [Related]
19. Composite score of reflux symptoms in diagnosis of gastroesophageal reflux disease.
Wang JH; Luo JY; Dong L; Gong J; Zuo AL
World J Gastroenterol; 2004 Nov; 10(22):3332-5. PubMed ID: 15484311
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Sweeney C; Gammon MD; Chow WH; Risch HA; Stanford JL; Hansten PD; Mayne ST; Schoenberg JB; Rotterdam H; Ahsan H; West AB; Dubrow R; Fraumeni JF; Blot WJ
Cancer Causes Control; 2000 Mar; 11(3):231-8. PubMed ID: 10782657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
